Suppr超能文献

乙酰次膦酸盐是丙酮酸脱氢酶复合体中人类和大肠杆菌丙酮酸脱氢酶组分最有效的基于机制的类底物抑制剂。

Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex.

作者信息

Nemeria Natalia S, Korotchkina Lioubov G, Chakraborty Sumit, Patel Mulchand S, Jordan Frank

机构信息

Department of Chemistry, Rutgers University, Newark, NJ 07102, USA.

出版信息

Bioorg Chem. 2006 Dec;34(6):362-79. doi: 10.1016/j.bioorg.2006.09.001. Epub 2006 Oct 27.

Abstract

Two analogues of pyruvate, acetylphosphinate and acetylmethylphosphinate were tested as inhibitors of the E1 (pyruvate dehydrogenase) component of the human and Escherichia coli pyruvate dehydrogenase complexes. This is the first instance of such studies on the human enzyme. The acetylphosphinate is a stronger inhibitor of both enzymes (Ki < 1 microM) than acetylmethylphosphinate. Both inhibitors are found to be reversible tight-binding inhibitors. With both inhibitors and with both enzymes, the inhibition apparently takes place by formation of a C2alpha-phosphinolactylthiamin diphosphate derivative, a covalent adduct of the inhibitor and the coenzyme, mimicking the behavior of substrate and forming a stable analogue of the C2alpha-lactylthiamin diphosphate. Formation of the intermediate analogue in each case is confirmed by the appearance of a positive circular dichroism band in the 305-306 nm range, attributed to the 1',4'-iminopyrimidine tautomeric form of the coenzyme. It is further shown that the alphaHis63 residue of the human E1 has a role in the formation of C2alpha-lactylthiamin diphosphate since the alphaHis63Ala variant is only modestly inhibited by either inhibitor, nor did either compound generate the circular dichroism bands assigned to different tautomeric forms of the 4'-aminopyrimidine ring of the coenzyme seen with the wild-type enzyme. Interestingly, opposite enantiomers of the carboligase side product acetoin are produced by the human and bacterial enzymes.

摘要

丙酮酸的两种类似物,乙酰次膦酸酯和乙酰甲基次膦酸酯,被测试作为人及大肠杆菌丙酮酸脱氢酶复合物中E1(丙酮酸脱氢酶)组分的抑制剂。这是对人酶进行此类研究的首例。乙酰次膦酸酯对两种酶(Ki < 1 microM)的抑制作用比乙酰甲基次膦酸酯更强。两种抑制剂均为可逆的紧密结合抑制剂。对于两种抑制剂和两种酶,抑制作用显然是通过形成C2α-膦酰基硫胺二磷酸衍生物发生的,该衍生物是抑制剂与辅酶的共价加合物,模拟底物行为并形成C2α-乳酰硫胺二磷酸的稳定类似物。每种情况下中间类似物的形成通过在305 - 306 nm范围内出现正圆二色性带得到证实,该带归因于辅酶的1',4'-亚氨基嘧啶互变异构形式。进一步表明,人E1的αHis63残基在C2α-乳酰硫胺二磷酸的形成中起作用,因为αHis63Ala变体仅受到两种抑制剂的适度抑制,两种化合物也均未产生与野生型酶所见辅酶4'-氨基嘧啶环不同互变异构形式相关的圆二色性带。有趣的是,人酶和细菌酶产生了羧化酶副产物乙偶姻的对映体。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验